137 related articles for article (PubMed ID: 21427132)
1. Severe relapse of multiple sclerosis during plasma exchange treatment.
Matzke B; Metze C; Winkelmann A; Grossmann A; Hartung HP; Benecke R; Zettl UK
Mult Scler; 2011 Jun; 17(6):759-62. PubMed ID: 21427132
[TBL] [Abstract][Full Text] [Related]
2. Dramatic worsening following plasma exchange in severe post-natalizumab withdrawal multiple sclerosis relapse.
Papeix C; Depaz R; Tourbah A; Stankoff B; Lubetzki C
Mult Scler; 2011 Dec; 17(12):1520-2. PubMed ID: 21669937
[TBL] [Abstract][Full Text] [Related]
3. Treatment of steroid unresponsive relapse with plasma exchange in aggressive multiple sclerosis.
Habek M; Barun B; Puretić Z; Brinar VV
Ther Apher Dial; 2010 Jun; 14(3):298-302. PubMed ID: 20609182
[TBL] [Abstract][Full Text] [Related]
4. Intravenous immunoglobulins are a therapeutic option in the treatment of multiple sclerosis relapse.
Elovaara I; Kuusisto H; Wu X; Rinta S; Dastidar P; Reipert B
Clin Neuropharmacol; 2011; 34(2):84-9. PubMed ID: 21301327
[TBL] [Abstract][Full Text] [Related]
5. Immunoadsorption in steroid-refractory multiple sclerosis: clinical experience in 60 patients.
Heigl F; Hettich R; Arendt R; Durner J; Koehler J; Mauch E
Atheroscler Suppl; 2013 Jan; 14(1):167-73. PubMed ID: 23357160
[TBL] [Abstract][Full Text] [Related]
6. Treatment of the First Acute Relapse Following Therapeutic Plasma Exchange in Formerly Glucocorticosteroid-Unresponsive Multiple Sclerosis Patients-A Multicenter Study to Evaluate Glucocorticosteroid Responsiveness.
Ehler J; Blechinger S; Rommer PS; Koball S; Mitzner S; Hartung HP; Leutmezer F; Sauer M; Zettl UK
Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28800066
[TBL] [Abstract][Full Text] [Related]
7. Simvastatin treatment in patients with relapsing-remitting multiple sclerosis receiving interferon beta 1a: a double-blind randomized controlled trial.
Togha M; Karvigh SA; Nabavi M; Moghadam NB; Harirchian MH; Sahraian MA; Enzevaei A; Nourian A; Ghanaati H; Firouznia K; Jannati A; Shekiba M
Mult Scler; 2010 Jul; 16(7):848-54. PubMed ID: 20488825
[TBL] [Abstract][Full Text] [Related]
8. Utility of neuropsychological testing for guiding treatment decisions in paediatric multiple sclerosis.
Penner IK; Hubacher M; Rasenack M; Sprenger T; Weber P; Naegelin Y
Mult Scler; 2013 Mar; 19(3):366-8. PubMed ID: 22740487
[TBL] [Abstract][Full Text] [Related]
9. Paradoxically aggressive multiple sclerosis in the face of natalizumab therapy.
Berger JR
Mult Scler; 2008 Jun; 14(5):708-10. PubMed ID: 18566035
[TBL] [Abstract][Full Text] [Related]
10. Extracorporeal photochemotherapy: a safety and tolerability pilot study with preliminary efficacy results in refractory relapsing-remitting multiple sclerosis.
Cavaletti G; Perseghin P; Dassi M; Cavarretta R; Frigo M; Caputo D; Stanzani L; Tagliabue E; Zoia C; Grimaldi M; Isella V; Rota S; Ferrarese C; Frattola L
Neurol Sci; 2006 Apr; 27(1):24-32. PubMed ID: 16688596
[TBL] [Abstract][Full Text] [Related]
11. Barkhof magnetic resonance imaging criteria predict early relapse in pediatric multiple sclerosis.
Neuteboom RF; Ketelslegers IA; Boon M; Catsman-Berrevoets CE; Hintzen RQ;
Pediatr Neurol; 2010 Jan; 42(1):53-5. PubMed ID: 20004863
[TBL] [Abstract][Full Text] [Related]
12. Multiple sclerosis relapses: a multivariable analysis of residual disability determinants.
Vercellino M; Romagnolo A; Mattioda A; Masera S; Piacentino C; Merola A; Chiò A; Mutani R; Cavalla P
Acta Neurol Scand; 2009 Feb; 119(2):126-30. PubMed ID: 18684216
[TBL] [Abstract][Full Text] [Related]
13. Magnetization transfer magnetic resonance imaging and clinical changes in patients with relapsing-remitting multiple sclerosis.
Oreja-Guevara C; Charil A; Caputo D; Cavarretta R; Sormani MP; Filippi M
Arch Neurol; 2006 May; 63(5):736-40. PubMed ID: 16682543
[TBL] [Abstract][Full Text] [Related]
14. T cell vaccination in multiple sclerosis relapsing-remitting nonresponders patients.
Achiron A; Lavie G; Kishner I; Stern Y; Sarova-Pinhas I; Ben-Aharon T; Barak Y; Raz H; Lavie M; Barliya T; Faibel M; Cohen IR; Mandel M
Clin Immunol; 2004 Nov; 113(2):155-60. PubMed ID: 15451472
[TBL] [Abstract][Full Text] [Related]
15. [Plasma immunoadsorption treatment of malignant multiple sclerosis with severe and prolonged relapses].
de Andrés C; Anaya F; Giménez-Roldán S
Rev Neurol; 2000 Apr 1-15; 30(7):601-5. PubMed ID: 10859735
[TBL] [Abstract][Full Text] [Related]
16. [Clinical features of relapsing remitting-multiple sclerosis. Prognostic factors].
Fernández-Fernández O
Rev Neurol; 2002 Dec 1-15; 35(11):1067-73. PubMed ID: 12497314
[TBL] [Abstract][Full Text] [Related]
17. [General practitioners' approach to relapsing multiple sclerosis].
Mackowiak A; Jamart V; Donze C; Hautecoeur P;
Rev Neurol (Paris); 2003 Feb; 159(2):196-8. PubMed ID: 12660572
[TBL] [Abstract][Full Text] [Related]
18. Chronic cerebro-spinal venous insufficiency: report of transcranial magnetic stimulation follow-up study in a patient with multiple sclerosis.
Plasmati R; Pastorelli F; Fini N; Salvi F; Galeotti R; Zamboni P
Int Angiol; 2010 Apr; 29(2):189-92. PubMed ID: 20351675
[TBL] [Abstract][Full Text] [Related]
19. Atorvastatin combined to interferon to verify the efficacy (ACTIVE) in relapsing-remitting active multiple sclerosis patients: a longitudinal controlled trial of combination therapy.
Lanzillo R; Orefice G; Quarantelli M; Rinaldi C; Prinster A; Ventrella G; Spitaleri D; Lus G; Vacca G; Carotenuto B; Salvatore E; Brunetti A; Tedeschi G; Brescia Morra V
Mult Scler; 2010 Apr; 16(4):450-4. PubMed ID: 20150398
[TBL] [Abstract][Full Text] [Related]
20. Can pathological patterns be used to guide individualized multiple sclerosis therapy?
Chan A; Gold R
Nat Clin Pract Neurol; 2006 Feb; 2(2):72-3. PubMed ID: 16932526
[No Abstract] [Full Text] [Related]
[Next] [New Search]
